SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019840
Filing Date
2024-05-15
Accepted
2024-05-15 16:06:27
Documents
71
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 878175
2 ex31-1.htm EX-31.1 12723
3 ex31-2.htm EX-31.2 12711
4 ex32-1.htm EX-32.1 6278
5 ex32-2.htm EX-32.2 6317
  Complete submission text file 0001493152-24-019840.txt   5083555

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE tcbp-20240331.xsd EX-101.SCH 47935
7 XBRL CALCULATION FILE tcbp-20240331_cal.xml EX-101.CAL 51611
8 XBRL DEFINITION FILE tcbp-20240331_def.xml EX-101.DEF 161353
9 XBRL LABEL FILE tcbp-20240331_lab.xml EX-101.LAB 366615
10 XBRL PRESENTATION FILE tcbp-20240331_pre.xml EX-101.PRE 277413
75 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 730182
Mailing Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR
Business Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR 01414337557
TC BioPharm (Holdings) plc (Filer) CIK: 0001872812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41231 | Film No.: 24950470
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)